Company: SUNE
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029179
Chunk: 12

Company: SUNation Energy, Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 12
---
 to an issuance date reset adjustment. Each Series B Warrant will have an initial exercise price of $2.875 per share (not to exceed 250% of the combined public offering price), which will be subject to an issuance date reset adjustment. Each common warrant will expire five years from the initial issuance date. Each of the common warrants will be exercisable immediately upon issuance. For more information on the common warrants, including certain price protection provisions and issuance date adjustments of such warrants, see “Description of Common Warrants.”  This prospectus supplement also relates to the offering of the shares of common stock issuable upon exercise of the common warrants. |
| Common stock outstanding immediately before this offering |     | 16,278,067 shares                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Common stock outstanding immediately after this offering  |     | 20,625,893 shares, and assuming none of the common warrants issued in this offering are exercised.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Nasdaq Capital Market symbol                              |     | SUNE; there is no established public trading market, however, for the common warrants, and we do not intend to list these securities on any national securities exchange or trading system.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Use of proceeds                                           |     | We currently intend to use the net proceeds from this offering under this prospectus supplement to repay existing certain existing debt obligations, as well as for working capital and general corporate purposes. See “Use of Proceeds” on page S-9 of this prospectus supplement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Risk factors                                              |     | See “Risk Factors” on page S-3 and the other information included or incorporated by reference in this prospectus supplement, and the accompanying prospectus for a discussion of certain factors you should carefully consider before deciding to invest in shares of our common stock.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

The number of shares of common stock to be outstanding after this offering, as reflected above, is based on 16,278,067 shares of common stock outstanding at April 4, 2025 and excludes the following:

| ● | 12,676                                                                      
 shares of common stock issuable pursuant to our 2022 Equity Incentive Plan; |

| ● | 400                                                                                    
 shares of common stock issuable pursuant to our 2022 Employee Stock Purchase Plan; and |

| ● | 60                                                                          
 shares of common stock issuable pursuant to our SUNation Inducement Grants.